Search Results for: PFE
Webster Financial (WBS) Bank needs to raise cash. Falls to $21.77 from 52-week high of $46.40. Pfizer (PFE) Concerns about product pipeline. Sells down to $18.45 from 52-week high of $27.33. Nokia...
Published:
Pfizer Inc. (NYSE: PFE) is stopping its Phase III clinical trial of Sutent early. This is generally a scare over adverse events, but not in this case. Sutent apparently has shown such a...
Published:
Last Updated:
It is hard to say whether a person is better off stopping smoking and lessening their chances of a heart attack or killing themselves. Some of the anti-smoking drugs from Pfizer (PFE) and...
Published:
Last Updated:
Pfizer, Inc (NYSE: PFE) has signed an agreement with the much smaller AVANT Immunotherapeutics (NASDAQ: AVAN). The two have announced an agreement where Pfizer will be granted an exclusive...
Published:
Last Updated:
These are some of the top analyst downgrades we have seen this Friday morning: Americredit (ACF) Raised to Market Perform at FBR. Cliff’s Natural resources (CLF) Cut to Market Perform at FBR. CV...
Published:
Last Updated:
Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to meet both the cognitive and functional endpoints in...
Published:
It’s the BioHeath Daily for key developments in drugs, biotech, and medical developments. Prana Biotechnology Ltd. (NASDAQ: PRAN) is often overlooked here in the U.S. as it has such a small...
Published:
Last Updated:
Icagen Inc. (NASDAQ: ICGN) has announced that it has provided notice to exercise its put option with Pfizer Inc. (NYE: PFE). This is for the private placement of approximately $10 million of...
Published:
This morning Cramer on TheStreet.com posted his comments regarding Pfizer’s (PFE) drug blow-up this weekend. You’ll need to go visit thestreet.com there about what he said exactly,...
Published:
The Nigerian government is suing Pfizer (PFE) claiming that it "deceived patients and caused the death of 11 children in 1996 when it performed clinical trials for a new drug." According to...
Published:
Pfizer Inc. (NYSE: PFE) has a big day ahead of it. While it has been known for years, it is a massive date: Lipitor goes off-patent and will have generic versions of the statin drug competitors....
Published:
These are some of the top pre-market analyst upgrades and positive calls we have seen this Monday morning: Adobe Systems (ADBE) Raised to Outperform at Oppenheimer. Alexion Pharmaceuticals (ALXN)...
Published:
Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning. The results of both drug behemoths are largely in line with analysts...
Published:
CyDex Pharmaceuticals, Inc. has filed to come public via an IPO in what it lists for filing purposes as up to $50 million in securities sales. It has applied to have the common stock approved...
Published: